Targeted protein degradation in cancer: strategies for undruggable targets and progress towards clinical translation
Targeted protein degradation (TPD) has significantly influenced cancer therapy by enabling the targeting of traditionally undruggable oncogenic drivers such as transcription factors, chromatin remodelers, and mediators of protein-protein interactions, overcoming limitations of conventional inhibitors. This approach har...